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Inthetreatmentofdistalrectal cancer, abdominoperineal resection is traditionally performed. However, the recognition of shorter
safe distal resection line, intersphincteric resection technique has given a chance of sphincter-saving surgery for patients with distal
rectal cancer during last two decades and still is being performed as an alternative choice of abdominoperineal resection. The ﬁrst
aim of this study is to assess the morbidity, mortality, oncological, and functional outcomes of intersphincteric resection. The
second aim is to compare outcomes of patients who underwent intersphincteric resection with the outcomes of patients who
underwent abdominoperineal resection.
1.Introduction
Colorectal cancer is the third most common cancer and the
fourth leading cause of cancer death worldwide. It is also the
second most common cancer in women and the third most
c o m m o ni nm e nw i t h i nE u r o p e a nc o u n t r i e s[ 1]. Although
colon cancer and 2/3 proximal rectal cancer are treated more
easily, treatment of distal rectal cancer involves challenges
even colorectal surgeons. Abdominoperineal resection
(APR) has been the usual treatment option for distal rectal
cancer since Miles reported this technique in the 1920 [2].
However, APR inevitably includes permanent colostomy.
Total mesorectal excision technique was described by Heald
and Ryall and this is the gold standard management of
middle and distal thirds of rectal cancer now. This technique
both reduced the recurrence rate and increased the survival
of the rectal cancer [3]. In addition, further studies
suggested that distal intramural spread of rectal cancer rarely
extends more than 1cm beyond the distal margin of the
tumor [4, 5]. Therefore, along with advances in preoperative
chemoradiation therapy, a 1cm distal margin has
increased the incidence of successful sphincter-saving
surgery [6]. Schiessel et al. ﬁrst reported the intersphincteric
resection (ISR) technique which has been used to increase
sphincter preservation by achieving necessary distal margin
for patients with distal rectal cancers [7]. Today, ISR and
coloanal anastomosis are commonly preferred surgical
treatment options of distal rectal cancer. The aim of this
paper is to evaluate the mortality and morbidity, oncologic
and functional outcomes after ISR for distal rectal cancer.
2. MaterialsandMethods
A literature search of Medline, Embase, Ovid, and Cochrane
database was performed to identify relevant articles in the
English language associated with ISR for rectal cancer for the
years 1960 to 2012.
3.SurgicalTechnique
MRI and EUS are commonly used preoperative staging
rectal cancer. In addition these two modalities, in evaluating
whether a distal rectal cancer is eligible for ISR surgeons,
use rigid proctoscopy and digital assessment of the level of
the tumor in relation to the anal sphincter. Neoadjuvant
treatment is performed T3, T4, and N positive rectal cancer
for down staging and increase of possibility of sphincter-
saving surgery. Common practice is performed to surgery
within 6 weeks after neoadjuvant therapy [8].2 International Journal of Surgical Oncology
The indication forISRis anytype ofdistal cancerextend-
ing or involving the anal ring. The internal anal sphincter
involvement is also included. The tumors invading external
anal sphincter or levator ani muscle and T4 cancers did
not respond to neoadjuvant therapy, involving the prostate
or vagina, preoperative poor sphincter functions are con-
traindications of ISR. The most common indication for ISR
is cancer within 1cm of the anorectal ring. ISR and coloanal
anastomosis are performed as both abdominal and perineal
approach. Abdominal part of the operation is performed
either as open or laparoscopic technique [9–11].
Theﬁrststepofabdominalpartishighligationofinferior
mesenteric artery and left colonic mobilization including
takedown of splenic ﬂexure almost all patients. Second step
is total mesorectal excision, with sharp dissection along
an embryologic plane between the mesorectal fascia and
the fascia of the pelvic sidewall and preserving hypogastric
plexus nerves according to the method described by Heald
[12]. The dissection is performed as distal as possible and
the puborectal muscle surrounding lateral and posterior wall
of the rectum is exposed at the pelvic ﬂoor to facilitating
the perineal dissection. The ﬁrst step of the perineal part of
the operation is good exposition of the anal canal via self-
retaining retractor (Lone Star Retractor; Lone Star Medical
Products Inc., Houston, TX, USA). After injecting 1mg
diluted epinephrine in 20mL of saline solution which min-
imized bleeding and facilitating intersphincteric dissection,
the mucosa and internal sphincter are circumferentially
incised at least 1cm distance from the distal edge of the
tumor. The anal oriﬁce is then closed transanally with purs-
estring sutures to prevent tumor cell dissemination during
the perineal approach. There are 3 types of ISR, called total,
subtotal, and partial. When the tumor spread beyond the
dentate line, total ISR should be done. The internal sphincter
is completely removed, and the distal margin of resection
is at the intersphincteric groove. If the distal edge of the
tumorismorethan2cmfarfromdentateline,subtotalISRis
performedinsteadoftotalISR.Thedistalresectionmarginof
subtotal ISR is between dentate line and the intersphincteric
groove. If the surgeon has a enough distal surgical margin,
the distal line of the resection can be on or above the dentate
line. This is called parial ISR. The descriptions of 3 type of
ISR are shown in Figure 1. Dissection continues through
intersphincteric plane to connect with dissection from
abdomen.
After the rectum is totally separated from prostate or
vagina, the specimen is removed per anally. Frozen-section
histopathology should conﬁrm the lack of tumor cells in
the distal margin. Colonic J pouch, transverse coloplasty, or
straight coloanal hand-sewn anastomosis can be performed
according to surgeons preference. However, the latter associ-
ated with high incidence of tenesmus, urgency, and inconti-
nence [13]. Pelvic drain is placed, and defunctioning stoma
is created in most of patients.
4. Results
4.1. Morbidity and Mortality. ISR and coloanal anastomosis
associate with complications and mortality like any other
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Figure 1: Type of ISR according to amount of excision of the
internal anal sphincter. a: partial ISR, b: subtotal ISR, and c: total
ISR.
colorectal operations. Mortality rate of within postoperative
30 days was reported between 0 and 6 percent of patients in
the diﬀerent studies and is shown in Table 1. The common
causes of death both surgery related factor (e.g., anastomotic
leak) and consequence of comorbid medical conditions
(myocardial infarction, pulmonary embolus) have been
reported in the recently published meta-analysis [14].
The common complications of ISR are anastomotic leak-
age, stricture, ﬁstula, pelvic sepsis, bleeding, bowel obstruc-
tion, and wound infections, which have been reported in
diﬀerent studies and are shown in Table 1.A n a s t o m o t i c
leaks are inevitable complications that have been previously
reported to aﬀect 2.6% and 24% of patients undergoing col-
orectalsurgery[39,40].Likewise,themostseriouscomplica-
tion of ISR and coloanal anastomosis is anastomotic leakage.
Anastomotic leakage was deﬁned by the presence of a pelvic
abscess and was conﬁrmed by a computed tomography
scan or clinical peritonitis. Once the anastomotic leakage
is diagnosed, prompt management has a vital signiﬁcance.
Although diverting loop ileostomy is a common surgical
choice to secure an anastomosis or to divert feces from
a distal aﬀected intestinal segment, it has become clear
that an anastomotic leak cannot be prevented by a prox-
imal diversion, but septic symptoms can be reduced [41].
Anastomotic leakage has been reported 0.9–13% of ISR
surgery in the diﬀerent studies. The rate of pelvic sepsis is
reported up to 5 percent, majority of these originate from an
anastomotic leak [25]. Intraoperative blood transfusion and
pulmonarydiseasewerefoundtobeindependentriskfactors
for anastomotic leakage in the recent study [28].
Anastomotic leakage is managed by diverting ileostomy
(if not perform initial operation) or percutaneous drainage.
Ifthecauseofanastomoticleakageisischemicdistalsegment,
pouch excision and reanastomosis or stoma creation with
APR may be required.
Intestinal obstruction was deﬁned by a combination
of the following ﬁndings: abdominal distention, abdominal
pain, vomiting, and the presence of air-ﬂuid levels on a plain
abdominal radiograph during the postoperative period.International Journal of Surgical Oncology 3
Postoperative intestinal obstruction is presented between 0–
16% according to various studies, and most of the patients
manage conservatively [21, 32]. Failure of the conservative
management requires further surgery in a few patients.
Wound infection is the most common minor complica-
tion of the ISR surgery. Wound infection is deﬁned by the
presence of purulent discharge, erythema, and induration
o ft h ew o u n d .W o u n di n f e c t i o nh a sb e e nr e p o r t e du pt o9
percent (Table 1) .A l lo ft h ew o u n di n f e c t i o n sw e r et r e a t e d
successfully by open wound care.
4.2. Oncologic Outcomes
4.2.1. Locoregional Recurrence. The local recurrence rates
of diﬀerent studies regarding intersphincteric resection are
summarized in Table 2. The rates of isolated local recurrence
reported are between 2% and 31% in these studies.
Various studies have shown that intersphincteric resec-
tion does not increase local recurrence rates [31].
Recurrence rate of the distal rectal cancer was radically
reduced by total mesorectal excision technique which was
ﬁrst reported by Heald et al. Today the most of local
recurrence is considered as being incomplete of surgical
e x c i s i o n .H o w e v e r ,i n v o l v e m e n to fc i r c u m f e r e n t i a lr e s e c t i o n
margin is associated with high recurrence rate even if TME is
properly performed [36]. In addition, some authors argue
that involvement of lateral pelvic lymph node is responsible
up to 22% of locoregional recurrence [47].
Another important point of local recurrence is tumor
shedding. Cancer cells have been found on the peritu-
moral tissue and doughnuts after stapling anastomosis [48].
Because handling of the rectum during surgery causes
increased number of cancer cells shed, no touch technique
can be beneﬁcial [49].
4.2.2. Survival. Range of the 5-year overall survival rate of
intersphincteric resection was 62%–97%, and disease-free
survival was 66%–87% in the diﬀerent studies. (Table 2).
Recently published study has reported that 5-year overall
survival for patients after ISR was 80%, and disease-free sur-
vival was 69.1%. These results considered better than 5-year
overall survival of APR but not 5-year disease-free survival
[31].
Kuo et al. analyzed the comparison between low anterior
resection and stapled colorectal anastomosis, radical proc-
tectomy with ISR and APR. The authors found signiﬁcantly
diﬀerences in overall survival among three groups and
APR had statistically shorter survival than others [46]. All
these results suggest that intersphincteric resection is a safe
procedure in terms of oncologic outcomes.
4.3. Functional Outcomes. Preservation of the sympathetic
and parasympathetic nerves is one of the most important
part of the TME in the rectal cancer surgery. There are four
zone nerve damages that can occur. First, the root of the
inferior mesenteric artery (damage of sympathetic hypogas-
tric nerve); second, posterior rectal plane (damage of
sympathetic hypogastric nerve); third, lateral rectal plane
(sympathetic and parasympathetic nerves); fourth, anterior
rectal dissection (cavernous nerve). Damage of these nerves
causes urinary dysfunction or impotence in most of patients
[50].
Functional results of diﬀerent studies are shown in
Table 3. Jorge and Wexner incontinence score, the Kirwan
classiﬁcation system, and other institutional questionnaires
are usually used to evaluate patients’ functional results.
P o s t o p e r a t i v ef u n c t i o n a lo u t c o m e ss e e mt ob ea c c e p t a b l e .
Incontinence was a record of the number of bowel move-
mentsin24hoursalmostinallstudies.Thebowelmovement
rates from 2.2 to 3.7 per 24 hours and fecal soiling rate from
11% to 59% are reported. Rullier et al. show that if more
than half of the internal sphincter is resected, incontinence
is worse but remains normal in 50% patients [8]. Denost
et al. investigated risk factors fecal incontinence after ISR
in 101 rectal cancer patients and they found that the only
independent predictors of incontinence were distance of the
tumor lower than 1cm from the anal ring (P = 0.004) and
anastomoses lower than 2cm above the anal verge (P =
0.037)[51].Itshouldbeconsideredthatfunctionaloutcomes
may be improved by use of J pouch or coloplasty [52].
Before surgery, the patient must be informed about possible
functional outcomes of intersphincteric resection.
4.4. ISR versus APR. Although there are numerous studies
comparing sphincter-saving surgery and APR [44, 53], few
studies were found regarding comparison of ISR and APR
due to heterogeneity of the sphincter-saving surgery groups.
These studies are summarized in Table 4.
The study of Weiser et al. concluded that patients under-
going APR were elder (P = 0.0006) and have more poorly
diﬀerentiated tumors (P = 0.03). Although there was no sta-
tistical signiﬁcant diﬀerence in the pretreatment endorectal
ultrasound stage, APR was associated with poorer outcome
in this study. Saito et al. reported that though a signiﬁcant
diﬀerence in overall survival was observed, there was no
signiﬁcant diﬀerence in disease-free survival between ISR
and APR groups. The authors concluded that ISR appears
to be oncologically acceptable and can reduce the number of
APRs [31].
5. Discussion
Multimodality treatment has brought advances in treatment
of locally advanced rectal cancer during the last two decades.
TheSwedishRectalCancerTrial,assessingpreoperativeshort
course radiotherapy, found a beneﬁt in overall survival
compared to surgery alone [54]. In addition to this beneﬁt,
preoperative radiotherapy provides downsizing and down-
stagingwhichincreasepossibilityofsphincter-savingsurgery
in patients with distal rectal cancer. Preoperative radiother-
apy or chemoradiotherapy should be recommended for T3-4
or N1 rectal cancers [8].
Distal rectal cancer is considered surgical challenge even
by colorectal surgeons. The ISR technique is a valuable
sphincter-saving surgical treatment in patients with distal
rectal cancer. Patients selection for ISR is based upon careful4 International Journal of Surgical Oncology
Table 1: Complications and mortality after ISR.
Reference Anastomotic
leak (%)
Anastomotic
stricture
(%)
Fistula
(%)
Pelvic
sepsis (%)
Wound
complications
(%)
Bleeding
(%)
Bowel
obstruction
(%)
Rectal
mucosal
prolapse
(%)
Mortality
(%)
Braun et al.
[15] (1992) 10 3 0 0 8 0 3 NR 6
Bannon et al.
[16] (1995) 0.9 0.9 0.9 0.9 1.8 0.9 0.9 1.8 1.0
K¨ ohler et al.
[17] (2000) 48 10 19 0 6 3 10 NR 0
Kim et al.
[18] (2001) 6.2 6.2 4.2 NR NR NR 8.3 NR NR
T i r e te ta l .
[19] (2003) 11 NR NR 3.8 NR 3.8 NR NR 0
Luna-p´ erez
et al. [20]
(2003)
9.4 6.25 6.25 9.3 6.25 NR 6.25 NR NR
Rullier et al.
[21] (2005) 11 0 2 3 0 7 0 NR 0
Schiessel
et al. [22]
(2005)
NR NR 5.1 NR NR 0.8 NR NR 0.8
Hohenberger
et al. [23]
(2006)
NR NR NR NR NR NR NR NR 3
Saito et al.
[24] (2006)
10.1 0 1.3 4.4 0 1.3 0 1.3 0.4
Chamlou
et al. [25]
(2007)
90 1 5 1 2 0 N R 0
Dai et al. [26]
(2008)
NR 8.7 8.7 NR NR NR NR NR 0
Akasu et al.
[27] (2008)
13.0 NR NR NR NR NR NR NR 0.8
Akasu et al.
[28] (2010)
13 0.8 NR NR 6.6 NR 5 0.8 0.8
Han et al.
[29] (2009)
30 0 0 5 0 0 N R 0
Krand et al.
[30] (2009)
42 0 2 9 0 2 N R 0
Saito et al.
[31] (2009)
NR NR NR NR NR NR NR NR 0
Weiser et al.
[32] (2009)
51 6 5 070 1 6 N R 0
Yamada et al.
[33] (2009)
4.7 8.4 0 0 3.7 0 8.4 3.7 0
Han et al.
[34] (2010)
1.6 2.5 0.6 NR NR NR NR NR NR
Park et al.
[35] (2011)
6.2 1.3 NR NR NR NR 2.5 NR 1.3
Lim et al.
[36] (2011)
1.8 6.3 0.9 2.7 NR NR 4.5 1.8 0
Bennis et al.
[37] (2012)
7 NR NR NR NR 1.6 2.69 NR 0.4
Reshef et al.
[38] (2012)
NR NR NR 2.9 4.5 NR NR NR 0.7International Journal of Surgical Oncology 5
Table 2: Oncologic results of ISR.
Reference Year N Median followup Local recurrence 5-year survival (overall) 5-year survival (disease free)
Braun et al. [15] 1992 63 80 11 62 NR
Marks et al. [42] 1993 52 50 14 85 NR
Bannon et al. [16] 1995 109 40 11.0 87 NR
Mohiuddin et al. [43] 1998 48 48 15 82 NR
K¨ ohler et al. [17] 2000 31 82 10 79 NR
Kim et al. [18] 2001 48 26 4.1 NR NR
T i r e te ta l .[ 19] 2003 26 39 3.4 NR NR
Nakagoe et al. [44] 2004 184 47.4 9.5 NR 73.6
Rullier et al. [21] 2005 92 40 2 81 70
Yoo et al. [45] 2005 29 57 31 86.2 65.7
Schiessel et al. [22] 2005 121 94 5.3 88 NR
Hohenberger et al. [23] 2006 65 70 23 NR NR
Saito et al. [24] 2006 228 41 3.6 92 83
Chamlou et al. [25] 2007 90 56 7 82 75
Dai et al. [26] 2008 23 31.5 8.7 NR NR
Akasu et al. [27] 2008 120 42 6.7 91 77
Krand et al. [30] 2009 47 68 2 85 82
Han et al. [29] 2009 40 43 5 97 86
Yamada et al. [33] 2009 107 41 2.5 92 87
Weiser et al. [32] 2009 44 47 0 96 83
Saito et al. [31] 2009 132 40 10.6 80 69
Han et al. [34] 2010 310 84 11.6 66 NR
Lim et al. [36] 2011 111 29.4 5.4 NR NR
Kuo et al. [46] 2011 162 55 7.7 83 76
Reshef et al. [38] 2012 986 60 3 71 69
preoperativestaging.Thelevelofthetransectionoftheinter-
nal sphincter should be decided before surgery. Detection of
preoperative external sphincter invasion or fecal inconti-
nence is all contraindication of ISR. In addition, some
authors argue that ISR is contraindicated to poorly diﬀeren-
tiated or mucinous cancer [7, 55].
Recently published systematic review reported that the
overall mortality associated with ISR is 0.8%. The overall
morbidity rate reported is 25.8%. Anastomotic leak was
experienced after a mean of 9.1% and the pelvic sepsis rate
was of 2.4% [14].
Postoperativeoverallmorbidityratevariesbetweenseries
from 8% to 64%. Anastomotic leak rates are reported of
0.9–48%. (Table 1) this diﬀerence arises from some studies
thatincludetheasymptomaticleakagewhichisradiologically
detected. Akasu et al. reviewed 120 patients who underwent
ISR and reported risk factors for anastomotic leakage
following ISR. This study suggests that intraoperative blood
transfusion, pulmonary disease, and colonic J-pouch are
independent risk factors for leakage following ISR [28].
One of the main targets of surgical treatment of rectal
cancer is as possible as long disease-free survival. Therefore,
the most important question to answer is ISR technique
carries an increased risk local recurrence or decline survival.
Inthevariousstudies,rangeofthe5-yearoverallsurvivalrate
of intersphincteric resection was reported from 79% to 97%,
and disease-free survival was reported from 69% to 87%.
(Table 2).
Tilney and Tekkis reported review, including 21 studies
accumulating a total of 612 patients who underwent ISR
for distal rectal cancer. The mean 5-year survival following
ISR was reported in 81.5%. Locoregional recurrence rate
was available from all of the studies evaluated for oncologic
outcomes, with 51 of 538 patients (9.5%) experienced local
recurrence [56].
Akasu et al. investigated risk factors for local and distant
recurrence in 122 patients. Local recurrence rate found
6.7% and distant recurrence rate was found 13%. Positive
resection margins, dediﬀerentiation of tumor, and elevated
preoperative levels of CA19-9 (>37U/mL)werereportedrisk
factors of local recurrence. Pathological N1, N2 tumor, poor
diﬀerentiation, and the tumor close to anal canal less than
2 . 5c mw e r er e p o r t e dr i s kf a c t o rf o rd i s t a n tr e c u r r e n c e[ 27].
The current systematic review and meta-analysis which
included 14 studies reported that the mean distal margin
free from tumor was 17.1mm, CRM-negative margins were
achieved in 96% of patients, RO and the overall local
recurrence rate were 6.7% (range: 0–23%). The 5-year
overall and disease-free survival rate was 86.3% and 78.6%,
respectively [14]. The authors conclude that available datas
with potential for selection bias, oncological outcomes after
ISR are aﬀected negatively.
There are limited studies in the literature about func-
tional outcomes after ISR (Table 3). Jorge and Wexner
incontinence score and the Kirwan classiﬁcation system were
generally used for evaluating patient’ functional outcome6 International Journal of Surgical Oncology
Table 3: Functional results of ISR.
Reference Year n Anal
manometry Functional tool
Bowel
movements
per 24 hours
Complete
incontinence
(%)
Incontinence
to ﬂatus (%)
Faecal
soiling (%)
Urgency
(%)
Braun
et al. [15] 1992 63 No Mayo clinic
classiﬁcation 2.2 (1–3) 75 17 15 22
K¨ ohler
et al. [17] 2000 31 Yes General
questionnaire 3.3 (NR) 30 11 63 NR
Kim et al.
[18] 2001 48 No Kirwan
classiﬁcation 4.4 (3–6) NR NR NR NR
T i r e te ta l .
[19] 2003 25 No NR 2.5 (NR) 50 23 27 19
Schiessel
et al. [22] 2005 121 Yes
Williams and
johnston
classiﬁcation
2.2 (1–9) 86.3 NR 13.7 NR
Yoo et al.
[45] 2005 17 No
Cleveland clinic
incontinence
score
5.0 (2–9) NR 17.6 41.2 58.8
Saito et al.
[24] 2006 228 No
Jorge and
wexner
incontinence
score and
kirwan score
NR 32.7 29.1 29.1 NR
Chamlou
et al. [25] 2007 90 No
Jorge and
wexner
incontinence
score
2.3 (NR) 41 25 59 19
Yamada
et al. [33] 2009 107 No
Jorge and
wexner
incontinence
score and
Kirwan score
3.7 (2–6) 42.3 NR 27.9 NR
Han et al.
[29] 2009 40 No Kirwan
classiﬁcation 2.7 (NR) 43 29 29 31
Krand
et al. [30] 2009 47 No Kirwan
classiﬁcation 2.3 (2–5) 80 9 11 2
Kuo et al.
[46] 2011 22 No
Wexner
incontinence
score
4.7 (NR) NR NR NR 19
after ISR. Although neoadjuvant chemoradiotherapy has a
beneﬁcial eﬀect downsizing and downstaging in patients
undergoing ISR, it probably has a negative eﬀect on
functional results. Canda et al. showed that neoadjuvant
chemoradiotherapy was associated with signiﬁcantly lower
maximal squeeze pressures and worsening of Wexner scores
whohadreceivedneoadjuvantchemoradiotherapy[57].This
data support that counseling patients about expected func-
tional outcomes is important.
Current metaanalysis of 8 studies demonstrated that the
mean number of bowel motions in a 24h period was 2.7,
51.2% patients experienced “perfect incontinence”, 29.1%
patients experienced fecal soiling. Incontinence to ﬂatus is
reported by 23.8% in this study [14]. However, Bretagnol
et al. reported that the Wexner score and the Fecal Incon-
tinence Severity Index (FISI) were signiﬁcantly improved
following colonic j-pouch reconstruction compared with
straight coloanal anastomosis [58].
Quality of life after ISR has been rarely reported.
Bretagnol et al. demonstrated that fecal incontinence-related
QoL scores were poorer than LAR after ISR. However, SF
36 scores were similar [58]. Barisic et al. showed that fecal
incontinence improved by the time and 11.1% patients
had fecal incontinence after 1-year ISR. Moreover, most
of patients had acceptable QoL scores according to all
functionalandsymptomcomponentsoftheEuropeanOrga-
nization for Research and Treatment of Cancer QoL-C30
questionnaire [59].
Kuo et al. reported functional outcomes of ISR in 162
patients; 38% had stool fragmentation, 23.8% had nocturnal
defecation they reported and one-third needed antidiarrheal
medications. However, 90.8% of patients was satisﬁed with
functional results of ISR [46].
A few studies were found in the literature regarding
comparison of ISR and APR (Table 4). Almost all studies
reported low local recurrence rate and better survival for ISRInternational Journal of Surgical Oncology 7
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technique. All of these studies have retrospective characters,
and there could be bias about selection of the patients. How-
ever, only one study reported signiﬁcant diﬀerence between
ISR and APR by stage of rectal cancer [46]. Among these
studies, 5-year survival was compared between ISR and APR
by only one study regarding the stage of tumor. This study
reported that according the Dukes’ classiﬁcation, 5-year
survival rates for stages A, B, and C are 84%, 58%, and 27%,
respectively, for ISR patients and 83.5%, 53%, and 37%,
respectively, for APR patients [15]. Saito et al. published
the well-designed-study in this area. Although there were no
diﬀerence in patients’ age (P = 0.662), gender (P = 0.187),
and preoperative T (P = 0.798) and N (P = 0.521) stage,
signiﬁcant diﬀerence in overall survival was observed (P =
0.033) but no signiﬁcant diﬀerence in disease-free survival
between two groups (P = 0.714). There is one weak point in
this study that the most of the APR was performed between
1995 and 2002. Only 11 patients underwent APR between
2000 and 2006. The authors conclude that acceptable onco-
logic outcomes were gained with ISR, and the use of ISR can
reduce the number of APRs in patients with distal rectal
cancer [31].
6. Conclusion
The ISR technique provides an opportunity to perform
sphincter-saving surgery in treatment of distal rectal cancer.
The favorable tumor is early stage, well diﬀerentiated or has
a good regression after neoadjuvant therapy. This technique
performs with acceptable functional outcomes. Moreover, if
the adequate distal margin is provided, the local recurrence
and survival rates after ISR may even be better than those
of APR. The ISR technique should be considered as a safe
procedure and a valuable alternative to APR in selected
patients with distal rectal carcinomas.
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